Rubin Lewis J
University of California, San Diego School of Medicine, 9300 Campus Point Drive, La Jolla, CA 92032, USA.
Rheum Dis Clin North Am. 2008 Feb;34(1):191-7; viii. doi: 10.1016/j.rdc.2007.11.003.
Although progress has been made in treatment of pulmonary arterial hypertension, serious challenges remain. This article provides an overview of the challenges faced in treatment of PAH caused by scleroderma. It also provides a glimpse into the future, based on recent developments in the field that hold promise for enhancing the treatment of this disease.
尽管在肺动脉高压的治疗方面已取得进展，但严峻的挑战依然存在。本文概述了硬皮病所致肺动脉高压治疗中面临的挑战。基于该领域近期有望改善该病治疗的进展，本文还对未来进行了展望。
